Track And Treat In Nsclc (Tatin) - Ctdna Guided Treatment Of Early Resistance To Second-Line Osimertinib Treatment In Patients With Egfr Mutation Positive (Egfrm) Nsclc M. Jebbink, J. W. T. Van Der Wel,D. Van Den Broek, M. C. Boelens,K. Monkhorst, G. Ruiter,S. Burgers, L. Steinbusch,P. Baas, L. Kastelijn,E. E. Van Der Wall, M. Stellingwerf, E. F. F. Smit,A. J. De LangenANNALS OF ONCOLOGY（2021）引用 1|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
